Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171


Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.

Sun T, Sun BC, Zhao XL, Zhao N, Dong XY, Che N, Yao Z, Ma YM, Gu Q, Zong WK, Liu ZY.

Hepatology. 2011 Nov;54(5):1690-706. doi: 10.1002/hep.24543. Epub 2011 Jul 21.


Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.

Liu K, Sun B, Zhao X, Wang X, Li Y, Qiu Z, Gu Q, Dong X, Zhang Y, Wang Y, Zhao N.

Exp Mol Pathol. 2015 Oct;99(2):383-91. doi: 10.1016/j.yexmp.2015.08.009. Epub 2015 Aug 28.


Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.

Liu K, Sun B, Zhao X, Wang X, Li Y, Qiu Z, Liu T, Gu Q, Dong X, Zhang Y, Wang Y, Zhao N.

Int J Mol Med. 2015 Sep;36(3):783-91. doi: 10.3892/ijmm.2015.2293. Epub 2015 Jul 22.


Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.

Wang L, Lin L, Chen X, Sun L, Liao Y, Huang N, Liao W.

Oncotarget. 2015 May 10;6(13):11492-506.


Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.

Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.

J Cell Mol Med. 2011 Mar;15(3):691-700. doi: 10.1111/j.1582-4934.2010.01052.x.


Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.

Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.


Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.

Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N, Wang XH, Du J, Liu YX, Sun BC.

Hepatology. 2010 Feb;51(2):545-56. doi: 10.1002/hep.23311.


The twist box domain is required for Twist1-induced prostate cancer metastasis.

Gajula RP, Chettiar ST, Williams RD, Thiyagarajan S, Kato Y, Aziz K, Wang R, Gandhi N, Wild AT, Vesuna F, Ma J, Salih T, Cades J, Fertig E, Biswal S, Burns TF, Chung CH, Rudin CM, Herman JM, Hales RK, Raman V, An SS, Tran PT.

Mol Cancer Res. 2013 Nov;11(11):1387-400. doi: 10.1158/1541-7786.MCR-13-0218-T. Epub 2013 Aug 27.


Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.

Zhao N, Sun BC, Zhao XL, Wang Y, Meng J, Che N, Dong XY, Gu Q.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):15759-68. eCollection 2015.


The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study.

Che N, Zhao XL, Sun T, Zhao XM, Gu Q, Dong XY, Zhao N, Liu YR, Yao Z, Sun BC.

Hum Pathol. 2011 Jun;42(6):840-7. doi: 10.1016/j.humpath.2010.03.010. Epub 2011 Jan 3.


Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.

Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J, Sun T, Wang J, Sun R, Liu Y.

Gynecol Oncol. 2014 Jun;133(3):575-83. doi: 10.1016/j.ygyno.2014.02.034. Epub 2014 Feb 28.


Changes in microRNAs associated with Twist-1 and Bcl-2 overexpression identify signaling pathways.

Zhao N, Sun BC, Zhao XL, Wang Y, Sun HZ, Dong XY, Meng J, Gu Q.

Exp Mol Pathol. 2015 Dec;99(3):524-32. doi: 10.1016/j.yexmp.2015.08.018. Epub 2015 Sep 2.


Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.

Gajula RP, Chettiar ST, Williams RD, Nugent K, Kato Y, Wang H, Malek R, Taparra K, Cades J, Annadanam A, Yoon AR, Fertig E, Firulli BA, Mazzacurati L, Burns TF, Firulli AB, An SS, Tran PT.

Neoplasia. 2015 Jan;17(1):16-31. doi: 10.1016/j.neo.2014.10.009.


Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.

Tran DD, Corsa CA, Biswas H, Aft RL, Longmore GD.

Mol Cancer Res. 2011 Dec;9(12):1644-57. doi: 10.1158/1541-7786.MCR-11-0371. Epub 2011 Oct 17.


Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.

Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J.

Oncotarget. 2015 Aug 14;6(23):19580-91.


MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N.

Mol Carcinog. 2014 May;53(5):349-59. doi: 10.1002/mc.21983. Epub 2013 Sep 3.


The role of TWIST1 in epithelial-mesenchymal transition and cancers.

Zhu QQ, Ma C, Wang Q, Song Y, Lv T.

Tumour Biol. 2016 Jan;37(1):185-97. doi: 10.1007/s13277-015-4450-7. Epub 2015 Nov 24. Review.


Twist1-induced invadopodia formation promotes tumor metastasis.

Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, Yang J.

Cancer Cell. 2011 Mar 8;19(3):372-86. doi: 10.1016/j.ccr.2011.01.036.


ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.

Banerjee A, Wu ZS, Qian P, Kang J, Pandey V, Liu DX, Zhu T, Lobie PE.

Breast Cancer Res. 2011;13(6):R112. doi: 10.1186/bcr3054. Epub 2011 Nov 7.


Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.

Zhang D, Sun B, Zhao X, Ma Y, Ji R, Gu Q, Dong X, Li J, Liu F, Jia X, Leng X, Zhang C, Sun R, Chi J.

Mol Cancer. 2014 Sep 8;13:207. doi: 10.1186/1476-4598-13-207.

Supplemental Content

Support Center